Global Healthcare Study on Hidradenitis Suppurativa
- Hidradenitis Suppurativa (HS)
- Hidradenitis Suppurativa (Acne Inversa)
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- Julia Tatjana Maul
- Enrolment target
- 9,600
- Started
- 1 January 2025
- Main results due
- 31 December 2029
- Study sites
- 1
- Registry updated
- 28 September 2026
Can you take part?
- Aged 14 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Signed General Consent Form, or equivalent document * Confirmed diagnosis of Hidradenitis Suppurativa Exclusion Criteria: * Inability to provide informed consent. * Datasets with ambiguous or unclear diagnosis.
What this study is about
In the sponsor’s own words, from the registry.
The Global Healthcare Study on Hidradenitis Suppurativa (GHSHS) is an international, multicenter observational study hosted by the University of Zurich (UZH) investigating healthcare access, treatment patterns, disease severity, and quality of life in patients with hidradenitis suppurativa. The study collects standardized clinical data from routine medical records to identify disparities in healthcare delivery and outcomes across different healthcare systems.
Study sites(1)
University of Zurich
Zurich, Switzerland
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07659769. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me